Wang, Y., Tong, Z., Zhang, W., Zhang, W., Buzdin, A., Mu, X., . . . Li, X. (2021). FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients. Front Oncol.
استشهاد بنمط شيكاغوWang, Ye, et al. "FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients." Front Oncol 2021.
MLA استشهادWang, Ye, et al. "FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients." Front Oncol 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.